Komori
Takara Holdings (2531) · TargetReframed

Consolidated Quantitative Targets under TaKaRa Group Medium-Term Management Plan 2016

First written in FY2016. 18 of 23 entries say "Restated". Latest entry: FY2026.

23entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018-Q2 – FY2020-Q3RestatedFY2021-Q1 – FY2023-Q2RestatedFY2024-Q3 – FY2026-H12016: 320162017: 320172018: 320182019: 220192020: 420202021: 320212022: 120222023: 120232024: 120242025: 120252026: 12026
Same theme, other companies
Setting and Achieving Performance Targets Under the Medium-Term Management PlanA theme 811 companies write about · 76 as a headwind · 1086 as a tailwind

Takara Holdings moved to the "Worse" side of this theme in 2026, 4 years after the typical company in this theme (2022).

The whole theme swung hardest in 2021: 17 of 78 companies on the "Worse" side.

17 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 133 companies compared. The sentences above are computed from all 133.Comparing 200 of the theme's 1207 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026ReframedAnnual report

    「財務目標 宝グループ連結 2031年3月期           (参考:2028年3月期) ROIC 7%以上 ROE 10%以上 営業利益 378億円以上 売上高 4,930億円以上」

    中期経営計画2025の2026年3月期目標から、中期経営計画2030の2031年3月期目標へ定量目標を切り替えた。参考として2028年3月期のROIC4.3%、ROE6.1%、営業利益235億円、売上高4,290億円も示している。
  2. FY2026-H1RestatedAnnual report

    「There were no material changes to the management policies, management strategies or other matters established by our group during the current interim consolidated accounting period.」

    中期経営計画およびその定量目標について、重要な変更がないと記載している。
  3. FY2024-Q3RestatedAnnual report

    「There were no significant changes to the management policies, management strategies or other matters established by our Group during the nine-month period ended December 31.」

    中期経営計画およびその定量目標について重要な変更がないと記載している。
  4. FY2023AchievedAnnual report

    「当連結会計年度は、その最終年度でありました。」

    中期経営計画2022が最終年度を迎えた。計画の定量目標である売上高3,000億円以上、営業利益174億円以上、海外売上高比率39%以上、ROE7%以上に対し、実績はそれぞれ3,506億65百万円、379億45百万円、48.3%、11.0%となり、記載された指標はいずれも目標値を上回った。
  5. FY2023-Q2RestatedAnnual report

    「There were no significant changes to the management policies, management strategies or other matters established by our Group during the six-month period ended September 30.」

    中期経営計画2022およびその定量目標について、重要な変更がないと記載している。
  6. FY2022-Q2RestatedAnnual report

    「There were no significant changes to the management policies, management strategies or other matters established by our Group during the six-month period ended September 30.」

    中期経営計画2022およびその定量目標について、重要な変更がないことを確認している。今回の記載では新たな定量目標は示していない。
  7. FY2021RestatedAnnual report

    「なお、現時点で新型コロナウイルス感染症の収束に関する予測は困難であり、上記の中期経営計画の定量目標については、見直しを行っておりません。」

    2023年3月期の売上高3,000億円以上、営業利益174億円以上、海外売上高比率39%以上、ROE7%以上の定量目標を見直していないと記載している。
  8. FY2021-Q3RestatedAnnual report

    「新型コロナウイルス感染症の影響を注視しながら、環境変化に柔軟に対応し、強化すべき領域へ適切な経営資源の配分と投下を行い、収益力を高める多様な「価値」を生み出し続ける事業構造とグローバルなコーポレート機能の再構築を推し進めることで、国内外での持続的な成長の実現とグループの企業価値向上に向けて足元を固めることに注力してまいりました。」

    中期経営計画2022のもと、環境変化への対応、経営資源の配分、事業構造とグローバルなコーポレート機能の再構築を継続している。
  9. FY2021-Q2RestatedAnnual report

    「本年5月に公表した長期経営構想「TaKaRa Group Challenge for the 100th」の実行計画の第1ステップとしての「宝グループ中期経営計画2022」に取り組んでまいりました。」

    中期経営計画2022を長期経営構想の第1ステップとして進めていることを再確認しており、計画の重要な変更はないと記載している。
  10. FY2021-Q1RestatedAnnual report

    「Against this economic backdrop, under TaKaRa Group Medium-Term Management Plan 2022, the first step in the execution plan for the long-term management concept TaKaRa Group Challenge for the 100th, we worked to establish a foundation for sustainable growth in Japan and overseas and enhance Group corporate value by responding flexibly to changes in the operating environment, including the impact of COVID-19, appropriately allocating and investing management resources in areas requiring strengthening, and rebuilding a business structure that continuously creates diverse value to improve profitability and global corporate functions.」

    中期経営計画2022を長期経営構想の第1ステップとして進めていることを再確認している。新たな連結定量目標は示していない。
  11. FY2020ReframedAnnual report

    「定量目標 2023年3月期 宝グループ連結 ・売上高 3,000億円以上 ・営業利益 174億円以上 ・海外売上高比率 39%以上 ・ROE 7%以上」

    中期経営計画2016・2019から、「宝グループ中期経営計画2022」へ移行し、2023年3月期の連結定量目標を明示している。
  12. FY2020-Q3RestatedAnnual report

    「Under TaKaRa Group Medium-Term Management Plan 2019, the final step toward achieving the long-term management vision TaKaRa Group Vision 2020, we sought to further increase the overseas sales ratio and establish a balanced business platform capable of substantially increasing earnings regardless of changes in the operating environment by developing numerous competitive fields based on a broad, comprehensive lineup of products in Japan and overseas and many products with competitive advantages, and pursued steady business operations.」

    中期経営計画2019の内容を再掲しており、新たな連結定量目標は示していない。
  13. FY2020-Q2RestatedAnnual report

    「Under TaKaRa Group Medium-Term Management Plan 2019, the final step toward achieving the long-term management vision TaKaRa Group Vision 2020, we sought to further increase the overseas sales ratio and establish a balanced business platform capable of substantially increasing earnings regardless of changes in the operating environment by developing numerous competitive fields based on a broad, comprehensive lineup of products in Japan and overseas and many products with competitive advantages, and pursued steady business operations.」

    中期経営計画2019の内容を再掲しているが、新たな連結定量目標は示していない。
  14. FY2020-Q1RestatedAnnual report

    「長期経営ビジョン「宝グループ・ビジョン2020」の達成に向けた最終ステップとしての「宝グループ中期経営計画2019」のもと、海外売上高比率をさらに高めるとともに、国内外で抜け・モレのない商品と競争優位性をもった商品を多数もつことで、他社に勝てる分野を数多く築き上げ、どんな環境変化が起ころうとも収益を大きく伸長させることができるバランスのとれた事業基盤を確立することを目指し、着実な事業活動に努めました。」

    中期経営計画2016から切り替えた中期経営計画2019の内容を再掲しており、新たな連結定量目標は示していない。
  15. FY2019-Q2RestatedAnnual report

    「Under TaKaRa Group Medium-Term Management Plan 2019, the final step toward achieving the long-term management vision TaKaRa Group Vision 2020, we sought to further increase the overseas sales ratio and establish a balanced business platform capable of substantially increasing earnings regardless of changes in the operating environment by developing numerous competitive fields based on a broad, comprehensive lineup of products in Japan and overseas and many products with competitive advantages, and pursued steady business operations.」

    中期経営計画2019の内容を再掲している。新たな連結定量目標は示していない。
  16. FY2019-Q1RestatedAnnual report

    「Under TaKaRa Group Medium-Term Management Plan 2019, the final step toward achieving the long-term management vision TaKaRa Group Vision 2020, we sought to further increase the overseas sales ratio and establish a balanced business platform capable of substantially increasing earnings regardless of changes in the operating environment by developing numerous competitive fields based on a broad, comprehensive lineup of products in Japan and overseas and many products with competitive advantages, and pursued steady business operations.」

    中期経営計画2016から切り替えた中期経営計画2019の内容を再掲している。新たな連結定量目標は示していない。
  17. FY2018-Q3RestatedAnnual report

    「Beginning in the current fiscal year, the Group launched TaKaRa Group Medium-Term Management Plan 2019 as the final step toward achieving the long-term management vision TaKaRa Group Vision 2020. We worked steadily to raise the overseas sales ratio further, establish numerous areas in which we could outperform competitors by offering comprehensive product lineups with competitive advantages in Japan and overseas, and build a balanced business platform capable of significantly increasing earnings regardless of changes in the operating environment.」

    中期経営計画2016から切り替えた中期経営計画2019について、前四半期と同じ計画内容を再掲している。新計画の定量目標は示されていない。
  18. FY2018-Q2RestatedAnnual report

    「Beginning in the current fiscal year, the Group launched TaKaRa Group Medium-Term Management Plan 2019 as the final step toward achieving the long-term management vision TaKaRa Group Vision 2020. We worked steadily to raise the overseas sales ratio further, establish numerous areas in which we could outperform competitors by offering comprehensive product lineups with competitive advantages in Japan and overseas, and build a balanced business platform capable of significantly increasing earnings regardless of changes in the operating environment.」

    中期経営計画2016から切り替えた中期経営計画2019について、前四半期と同じ計画内容を再掲している。
  19. FY2018-Q1ReframedAnnual report

    「Beginning in the current fiscal year, the Group launched TaKaRa Group Medium-Term Management Plan 2019 as the final step toward achieving the long-term management vision TaKaRa Group Vision 2020. We worked steadily to raise the overseas sales ratio further, establish numerous areas in which we could outperform competitors by offering comprehensive product lineups with competitive advantages in Japan and overseas, and build a balanced business platform capable of significantly increasing earnings regardless of changes in the operating environment.」

    The plan was changed from Medium-Term Management Plan 2016 to Medium-Term Management Plan 2019, the final step toward Vision 2020. No quantitative targets for the new plan are provided.
  20. FY2017-Q3RestatedAnnual report

    「As TaKaRa Group Medium-Term Management Plan 2016 entered its final year, we continued working to improve profitability in Japan and expand and grow the business overseas, while aiming to transform the Group into a balanced business structure resilient to changes in the operating environment by accelerating growth in the bio business」

    The policy of continuing initiatives in Japan, overseas and the bio business during the final year of Medium-Term Management Plan 2016 is reiterated. The disclosure does not state the achievement status of the full-year quantitative targets.
  21. FY2017-Q2RestatedAnnual report

    「As TaKaRa Group Medium-Term Management Plan 2016 entered its final year, we continued working to improve profitability in Japan and expand and grow the business overseas, while aiming to transform the Group into a balanced business structure resilient to changes in the operating environment by accelerating growth in the bio business」

    The final year of Medium-Term Management Plan 2016 and the policy of continuing initiatives in Japan, overseas and the bio business are reiterated. The disclosure does not state the achievement status of the full-year quantitative targets.
  22. FY2017-Q1RestatedAnnual report

    「As TaKaRa Group Medium-Term Management Plan 2016 entered its final year, we continued working to improve profitability in Japan and expand and grow the business overseas, while aiming to transform the Group into a balanced business structure resilient to changes in the operating environment by accelerating growth in the bio business」

    The final year of Medium-Term Management Plan 2016 and the policy of continuing initiatives in Japan, overseas and the bio business are reiterated. The disclosure does not state the achievement status of the full-year quantitative targets.
  23. FY2016First statedAnnual report

    「Fiscal year ending March 2017, TaKaRa Group consolidated: net sales of at least ¥230 billion, operating income of at least ¥12 billion, and an overseas sales ratio of at least 16%.」

    The quantitative targets for the fiscal year ending March 2017 specify net sales, operating income and the overseas sales ratio.
Moved together

"Clinical Development and Commercialization of Gene and Cell Therapies" moved the same way as this thread, in the same document, in 3 of its 23 moves.

332222★123456
  1. ★This thread
  2. 1Clinical Development and Commercialization of Gene and Cell Therapies3×
  3. 2Impairment Losses on Fixed Assets3×
  4. 3Improving Domestic Earnings through the Development and Nurturing of High-Quality, Technologically Differentiated Products2×
  5. 4Price Volatility in Crude Distilled Alcohol, Rice and Other Raw Materials2×
  6. 5A business portfolio built on alcoholic beverages and seasonings as stable revenue sources, with health foods and biotech as growth businesses2×
  7. 6Concentration of management resources on biotechnology industry support, genetic medicine, and food biotechnology2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Takara Holdings's next results are scheduled for 2026-11-10. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.